Follow us on Twitter
twitter icon@FreshPatents

Browse patents:
Next
Prev

Selective and potent peptide inhibitors of kv1.3 / Amgen Inc.




Title: Selective and potent peptide inhibitors of kv1.3.
Abstract: Disclosed are compositions of matter having an amino acid sequence of SEQ ID NO:4, or a pharmaceutically acceptable salt thereof, including embodiments comprising a toxin peptide analog related to ShK, HmK, and AETX-K and pharmaceutical compositions or medicaments containing them along with a pharmaceutically acceptable carrier. Some embodiments include a half-life extending moiety. Also disclosed are a method of preventing or mitigating a relapse of a symptom of multiple sclerosis and a method of treating an autoimmune disorder using the compositions. ...


Browse recent Amgen Inc. patents


USPTO Applicaton #: #20120121591
Inventors: John K. Sullivan, Leslie P. Miranda, Colin V. Gegg, Shaw-fen Sylvia Hu, Edward J. Belouski, Justin K. Murray, Hung Nguyen, Kenneth W. Walker, Taruna Arora, Frederick W. Jacobsen, Yue-sheng Li, Thomas C. Boone


The Patent Description & Claims data below is from USPTO Patent Application 20120121591, Selective and potent peptide inhibitors of kv1.3.




← Previous       Next →
Advertise on FreshPatents.com - Rates & Info


You can also Monitor Keywords and Search for tracking patents relating to this Selective and potent peptide inhibitors of kv1.3 patent application.

###


Browse recent Amgen Inc. patents

Keyword Monitor How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Selective and potent peptide inhibitors of kv1.3 or other areas of interest.
###


Previous Patent Application:
Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein)
Next Patent Application:
Targeting antigens to human dendritic cells via dc-asialoglycoprotein receptor to produce il-10 regulatory t-cells
Industry Class:
Drug, bio-affecting and body treating compositions
Thank you for viewing the Selective and potent peptide inhibitors of kv1.3 patent info.
- - -

Results in 0.06308 seconds


Other interesting Freshpatents.com categories:
QUALCOMM , Monsanto , Yahoo , Corning ,

###

Data source: patent applications published in the public domain by the United States Patent and Trademark Office (USPTO). Information published here is for research/educational purposes only. FreshPatents is not affiliated with the USPTO, assignee companies, inventors, law firms or other assignees. Patent applications, documents and images may contain trademarks of the respective companies/authors. FreshPatents is not responsible for the accuracy, validity or otherwise contents of these public document patent application filings. When possible a complete PDF is provided, however, in some cases the presented document/images is an abstract or sampling of the full patent application for display purposes. FreshPatents.com Terms/Support
-g2-0.2282

66.232.115.224
Browse patents:
Next
Prev

stats Patent Info
Application #
US 20120121591 A1
Publish Date
05/17/2012
Document #
File Date
12/31/1969
USPTO Class
Other USPTO Classes
International Class
/
Drawings
0


Autoimmune Disorder Relapse

Follow us on Twitter
twitter icon@FreshPatents

Amgen Inc.


Browse recent Amgen Inc. patents



Drug, Bio-affecting And Body Treating Compositions   Immunoglobulin, Antiserum, Antibody, Or Antibody Fragment, Except Conjugate Or Complex Of The Same With Nonimmunoglobulin Material   Structurally-modified Antibody, Immunoglobulin, Or Fragment Thereof (e.g., Chimeric, Humanized, Cdr-grafted, Mutated, Etc.)   Antibody, Immunoglobulin, Or Fragment Thereof Fused Via Peptide Linkage To Nonimmunoglobulin Protein, Polypeptide, Or Fragment Thereof (i.e., Antibody Or Immunoglobulin Fusion Protein Or Polypeptide)  

Browse patents:
Next
Prev
20120517|20120121591|selective and potent peptide inhibitors of kv1.3|Disclosed are compositions of matter having an amino acid sequence of SEQ ID NO:4, or a pharmaceutically acceptable salt thereof, including embodiments comprising a toxin peptide analog related to ShK, HmK, and AETX-K and pharmaceutical compositions or medicaments containing them along with a pharmaceutically acceptable carrier. Some embodiments include a |Amgen-Inc
';